XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.23.1

Capital Stock and Share Repurchase | 6 Months Ended
--- | ---
Feb. 28, 2023
Earnings Per Share [Abstract] |
Capital Stock and Share Repurchase | Note 11. Earnings per Share and Shareholders' Equity The Company's Board of Directors has authorized the repurchase of shares of the Company's common stock under publicly announced share repurchase programs. Since the inception of the initial share repurchase program in fiscal 2012, the Company has repurchased 26,558,965 shares of common stock for $742.8 million. The Company suspended the initial share repurchase program in response to the COVID-19 pandemic in the third quarter of fiscal 2020. In March 2022, the Company's Board of Directors rescinded its prior share repurchase authorization and approved a new share repurchase program authorizing the repurchase of a total of 10,000,000 shares of the Company's outstanding common stock. The Company did not repurchase shares in either of the six months ended February 28, 2023 or 2022. As of February 28, 2023, the maximum number of shares that may yet be purchased under the program is 6,240,265 shares. The reconciliation between basic and diluted earnings per share is as follows (in thousands, except per share amounts):
| Three Months Ended February 28, |  | Six Months Ended February 28, |  |
| 2023 |  | 2022 |  | 2023 |  | 2022 |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |
Net earnings from continuing operations | $ | 7,158 |  |  | $ | 2,121 |  |  | $ | 13,568 |  |  | $ | 5,306 |  |  |  |  |
Net loss from discontinued operations | (2,661) |  |  | (900) |  |  | (1,618) |  |  | (1,297) |  |  |  |  |
Net earnings | $ | 4,497 |  |  | $ | 1,221 |  |  | $ | 11,950 |  |  | $ | 4,009 |  |  |  |  |
Denominator: |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding - basic | 57,042 |  |  | 60,387 |  |  | 56,964 |  |  | 60,324 |  |  |  |  |
Net effect of dilutive securities - stock based compensation plans | 458 |  |  | 302 |  |  | 445 |  |  | 331 |  |  |  |  |
Weighted average common shares outstanding - diluted | 57,500 |  |  | 60,689 |  |  | 57,409 |  |  | 60,655 |  |  |  |  |
Earnings per share from continuing operations: |  |  |  |  |  |  |  |  |  |  |
Basic | $ | 0.13 |  |  | $ | 0.04 |  |  | $ | 0.24 |  |  | $ | 0.09 |  |  |  |  |
Diluted | $ | 0.12 |  |  | $ | 0.03 |  |  | $ | 0.24 |  |  | $ | 0.09 |  |  |  |  |
Loss per share from discontinued operations: |  |  |  |  |  |  |  |  |  |  |
Basic | $ | (0.05) |  |  | $ | (0.01) |  |  | $ | (0.03) |  |  | $ | (0.02) |  |  |  |  |
Diluted | $ | (0.05) |  |  | $ | (0.01) |  |  | $ | (0.03) |  |  | $ | (0.02) |  |  |  |  |
Earnings per share:* |  |  |  |  |  |  |  |  |  |  |
Basic | $ | 0.08 |  |  | $ | 0.02 |  |  | $ | 0.21 |  |  | $ | 0.07 |  |  |  |  |
Diluted | $ | 0.08 |  |  | $ | 0.02 |  |  | $ | 0.21 |  |  | $ | 0.07 |  |  |  |  |
Anti-dilutive securities from stock based compensation plans (excluded from earnings per share calculation) | 1,986 |  |  | 1,037 |  |  | 1,402 |  |  | 941 |  |  |  |  |
*The total of Earnings per share from continuing operations and loss per share from discontinued operations may not equal Earnings per share due to rounding. |  |  |  |
The following table illustrates the changes in the balances of each component of shareholders' equity for the six months ended February 28, 2023 (in thousands):
| Common Stock |  | Additional Paid-in Capital |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Stock Held in Trust |  | Deferred Compensation Liability |  | Total Shareholders’ Equity
| Issued Shares |  | Amount |
Balance at August 31, 2022 | 83,397 |  |  | $ | 16,679 |  |  | $ | 212,986 |  |  | $ | (742,844) |  |  | $ | 966,751 |  |  | $ | (134,961) |  |  | $ | (3,209) |  |  | $ | 3,209 |  |  | $ | 318,611 |
Net earnings | — |  |  | — |  |  | — |  |  | — |  |  | 7,453 |  |  | — |  |  | — |  |  | — |  |  | 7,453 |
Other comprehensive loss, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,024 |  |  | — |  |  | — |  |  | 6,024 |
Stock contribution to employee benefit plans and other | 3 |  |  | 1 |  |  | 41 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 42 |
Vesting of equity awards | 84 |  |  | 17 |  |  | (17) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock based compensation expense | — |  |  | — |  |  | 2,155 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,155 |
Stock option exercises | 42 |  |  | 8 |  |  | 922 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 930 |
Tax effect related to net share settlement of equity awards | — |  |  | — |  |  | (969) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (969) |
Stock issued to, acquired for and distributed from rabbi trust | 3 |  |  | 1 |  |  | 76 |  |  | — |  |  | — |  |  | — |  |  | (30) |  |  | 30 |  |  | 77 |
Balance at November 30, 2022 | 83,529 |  |  | $ | 16,706 |  |  | $ | 215,194 |  |  | $ | (742,844) |  |  | $ | 974,204 |  |  | $ | (128,937) |  |  | $ | (3,239) |  |  | $ | 3,239 |  |  | $ | 334,323 |
Net earnings | — |  |  | — |  |  | — |  |  | — |  |  | 4,497 |  |  | — |  |  | — |  |  | — |  |  | 4,497 |
Other comprehensive income, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,243 |  |  | — |  |  | — |  |  | 1,243 |
Stock contribution to employee benefit plans and other | 2 |  |  | — |  |  | 49 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 49 |
Vesting of equity awards | 173 |  |  | 34 |  |  | (34) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock based compensation expense | — |  |  | — |  |  | 2,120 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,120 |
Tax effect related to net share settlement of equity awards | — |  |  | — |  |  | (1,505) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,505) |
Stock issued to, acquired for and distributed from rabbi trust | 28 |  |  | 6 |  |  | 55 |  |  | — |  |  | — |  |  | — |  |  | (81) |  |  | 81 |  |  | 61 |
Balance at February 28, 2023 | 83,732 |  |  | $ | 16,746 |  |  | $ | 215,879 |  |  | $ | (742,844) |  |  | $ | 978,701 |  |  | $ | (127,694) |  |  | $ | (3,320) |  |  | $ | 3,320 |  |  | $ | 340,788 |
The following table illustrates the changes in the balances of each component of shareholders' equity for the six months ended February 28, 2022 (in thousands):
| Common Stock |  | Additional Paid-in Capital |  | Treasury Stock |  | Retained Earnings |  | Accumulated Other Comprehensive Loss |  | Stock Held in Trust |  | Deferred Compensation Liability |  | Total Shareholders’ Equity
| Issued Shares |  | Amount |
Balance at August 31, 2021 | 83,022 |  |  | $ | 16,604 |  |  | $ | 202,971 |  |  | $ | (667,732) |  |  | $ | 953,339 |  |  | $ | (92,984) |  |  | $ | (3,067) |  |  | $ | 3,067 |  |  | $ | 412,198 |
Net earnings | — |  |  | — |  |  | — |  |  | — |  |  | 2,788 |  |  | — |  |  | — |  |  | — |  |  | 2,788 |
Other comprehensive income, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10,044) |  |  | — |  |  | — |  |  | (10,044) |
Stock contribution to employee benefit plans and other | 2 |  |  | 1 |  |  | 84 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 85 |
Vesting of equity awards | 67 |  |  | 17 |  |  | (17) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock based compensation expense | — |  |  | — |  |  | 6,147 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,147 |
Tax effect related to net share settlement of equity awards | — |  |  | — |  |  | (1,393) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,393) |
Stock issued to, acquired for and distributed from rabbi trust | 1 |  |  | — |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | (25) |  |  | 25 |  |  | 25 |
Balance at November 30, 2021 | 83,092 |  |  | $ | 16,622 |  |  | $ | 207,817 |  |  | $ | (667,732) |  |  | $ | 956,127 |  |  | $ | (103,028) |  |  | $ | (3,092) |  |  | $ | 3,092 |  |  | $ | 409,806 |
Net earnings | — |  |  | — |  |  | — |  |  | — |  |  | 1,221 |  |  | — |  |  | — |  |  | — |  |  | 1,221 |
Other comprehensive income, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,744 |  |  | — |  |  | — |  |  | 1,744 |
Stock contribution to employee benefit plans and other | 5 |  |  | 1 |  |  | 64 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 65 |
Vesting of equity awards | 247 |  |  | 46 |  |  | (46) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock based compensation expense | — |  |  | — |  |  | 2,142 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2,142 |
Tax effect related to net share settlement of equity awards | — |  |  | — |  |  | (1,980) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,980) |
Stock issued to, acquired for and distributed from rabbi trust | 1 |  |  | — |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | 3 |  |  | (3) |  |  | 25 |
Balance at February 28, 2022 | 83,345 |  |  | $ | 16,669 |  |  | $ | 208,022 |  |  | $ | (667,732) |  |  | $ | 957,348 |  |  | $ | (101,284) |  |  | $ | (3,089) |  |  | $ | 3,089 |  |  | $ | 413,023 |

X
- Definition Capital Stock and Share Repurchase [Text Block] + References No definition available. + Details
Name: | epac_CapitalStockandShareRepurchaseTextBlock
Namespace Prefix: | epac_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration